2012-02-11 04:06:01 - Recently published research from Global Markets Direct, "Anaplastic Astrocytoma - Pipeline Review, H1 2012", is now available at Fast Market Research

Anaplastic Astrocytoma - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Anaplastic Astrocytoma - Pipeline Review, H1 2012', provides an overview of the Anaplastic Astrocytoma therapeutic pipeline. This report provides information on the therapeutic development for Anaplastic Astrocytoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anaplastic Astrocytoma. 'Anaplastic Astrocytoma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
-

www.fastmr.com/prod/330136_anaplastic_astrocytoma_pipeline_revie ..


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Anaplastic Astrocytoma.
* A review of the Anaplastic Astrocytoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Anaplastic Astrocytoma pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Anaplastic Astrocytoma.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Anaplastic Astrocytoma pipeline depth and focus of Anaplastic Astrocytoma therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Anaplastic Astrocytoma Overview
Therapeutics Development
An Overview of Pipeline Products for Anaplastic Astrocytoma
Anaplastic Astrocytoma Therapeutics under Development by Companies
Anaplastic Astrocytoma Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Anaplastic Astrocytoma Therapeutics - Products under Development by Companies
Anaplastic Astrocytoma Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Anaplastic Astrocytoma Therapeutics Development
Peregrine Pharmaceuticals, Inc.
Antisense Pharma GmbH
Advantagene, Inc.
Reata Pharmaceuticals, Inc.
Tocagen Inc
Anaplastic Astrocytoma - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Cotara - Drug Profile
Trabedersen - Drug Profile
Berubicin - Drug Profile
Talampanel - Drug Profile
Temozolomide + Radiation Therapy - Drug Profile
CPT-11 - Drug Profile
MLN-518 + Bevacizumab - Drug Profile
Bevacizumab + Irinotecan - Drug Profile
Carboplatin + Cisplatin + Cyclophosphamide + Etoposide + Methotrexate + Temozolomide + Thiotepa + Vincristine + Stem cell transplantation + Radiation Therapy - Drug Profile
MLN-518 - Drug Profile
Avastin + AZD2171 - Drug Profile
Therapeutic allogeneic lymphocytes + Aldesleukin - Drug Profile
Temozolomide + Radiation Therapy - Drug Profile
AdV-tk + Valacyclovir + Radiation Therapy - Drug Profile
Imatinib - Drug Profile
Ritonavir + Lopinavir - Drug Profile
O6-Benzylguanine + Carmustine - Drug Profile
TEMODAR - Drug Profile
Temozolomide + Radiation Therapy - Drug Profile
Avastin - Drug Profile
Temozolomide - Drug Profile
Lomustine + Radiation Therapy - Drug Profile
Tarceva - Drug Profile
Temodar + Topotecan - Drug Profile
Bendamustine Hydrochloride - Drug Profile
Sorafenib + Temodar + Radiation therapy - Drug Profile
Aminolevulinic acid - Drug Profile
Dendritic cells + Imiquimod - Drug Profile
Temodar + SCH 66336 - Drug Profile
Filgrastim + Paclitaxel + Topotecan - Drug Profile
Bevacizumab + MLN-518 - Drug Profile
Temodar - Drug Profile
Carboplatin + Temozolomide + Thiotepa + Vincristine + Stem Cell Transplantion + Radiation Therapy - Drug Profile
Carmustine + Irinotecan Hydrochloride - Drug Profile
Pioglitazone hydrochloride - Drug Profile
Montanide ISA-51 + SVN53-67/M57-KLH + Sargramostim - Drug Profile
Erbitux - Drug Profile
Alloreactive Cytotoxic T Lymphocytes + Interleukin-2 - Drug Profile
Toca 511 + Toca FC - Drug Profile
Autologous Tumor Lysate-Pulsed DC Vaccine - Drug Profile
Temodal + Radiation Therapy - Drug Profile
AMD3100 + Avastin - Drug Profile
BIBF 1120 - Drug Profile
Bevacizumab + Carboplatin - Drug Profile
Temozolomide + Bevacizumab + Radiation Therapy - Drug Profile
Anaplastic Astrocytoma Therapeutics - Drug Profile Updates

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=330136&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.